NeoGenomics will report its third quarter 2025 financial results prior to the open of the U.S. financial markets on Tuesday, ...
RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused ...
GARDENA, CALIFORNIA / ACCESS Newswire / September 25, 2025 / OPEN Healthcare proudly announces the grand opening of its new state-of-the-art 23,000-square-foot clinical laboratory in Gardena, ...
NEW HAVEN, CONNECTICUT / ACCESS Newswire / October 7, 2025 / Momentum Consulting today announced a new collaboration with clinical lab industry leader, Robert Michel, to broaden awareness of its ...
Rapid urinary antigen testing is widely used for pneumonia diagnosis, yet it often lacks the consistency and traceability required in today’s clinical laboratories. This webinar explor ...
Investing.com -- Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) stock gained 5.4% on Monday after the company announced results from a study published in the American Journal of Transplantation ...
Initiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease screeningWALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today ...
Revvity said on Thursday that it has partnered with French drugmaker Sanofi on the development of a test for the early detection of type 1 diabetes (T1D). Revvity currently offers a research-use-only ...
The laboratory at Fargo Cass Public Health has been without a "moderate complexity" credential since July 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback